ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
Nuclear Energy Conference & Expo (NECX)
September 8–11, 2025
Atlanta, GA|Atlanta Marriott Marquis
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Aug 2025
Jan 2025
Latest Journal Issues
Nuclear Science and Engineering
September 2025
Nuclear Technology
August 2025
Fusion Science and Technology
Latest News
Chris Wagner: The role of Eden Radioisotopes in the future of nuclear medicine
Chris Wagner has more than 40 years of experience in nuclear medicine, beginning as a clinical practitioner before moving into leadership roles at companies like Mallinckrodt (now Curium) and Nordion. His knowledge of both the clinical and the manufacturing sides of nuclear medicine laid the groundwork for helping to found Eden Radioisotopes, a start-up venture that intends to make diagnostic and therapeutic raw material medical isotopes like molybdenum-99 and lutetium-177.
Paul W. Marshall, Jeffrey B. Lutz, James L. Kelly
Nuclear Technology | Volume 76 | Number 3 | March 1987 | Pages 400-407
Technical Paper | Chemical Processing | doi.org/10.13182/NT87-A33925
Articles are hosted by Taylor and Francis Online.
A need for characterization of the iodine source term used in safety calculations for hypothesized light water reactor core disruptive accidents has motivated a study in iodine volatility. Previous experimental studies have been directed at evaluating volatility of iodine at a single time shortly (1 to 12 h) after introduction into the aqueous phase. The very important variables of time in solution and gamma radiation dose rate for a range of iodine concentrations (10-8 to 10-5 gI/ml) and pHs(5, 9, and 11) are explored. All experiments were performed at ∼25°C, first in the absence of a significant radiation field and later with a gamma radiation dose rate ranging from 0.003 to 0.06 Mrad/h. Iodine was introduced as either molecular I2 or Nal with 131I(8.04-day half-life) as a tracer. Results of experiments with nonirradiated systems indicated very little volatility with Nal-initiated studies. The I2-initiated systems at pH 5 were the most volatile whereas experiments at pH 9 and 11 showed decreasing iodine volatility with time. From the experiments at pH 9, it is inferred that the partition coefficient of HOI is ∼1000. A pronounced radiation-induced reduction in iodine volatility in pH 5 iodide solutions has been demonstrated as well as a dose rate dependence in the transient phase. As with nonirradiated systems, irradiated alkaline solutions exhibit low volatility. A computer-based model incorporating water radiolysis and iodine radiolytic chemical reactions has been formulated and tested. The model successfully predicts radiation-induced volatility changes in pH 5 iodide systems. The experimentally observed dose rate dependence is also verified. At pH 9, the agreement between experimental results and predicted results is not good.